1st Quarter - Report

QUEST DIAGNOSTICS INCORPORATED for QUEST DIAGNOSTICS INCORPORATED

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$520,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Apr 22, 2024 $520,000 Replaced
1st Quarter - Amendment Oct 21, 2024 $430,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Federal policy and programs regarding oncology research and development related to cancer screening, diagnosis, and survivorship Federal policy related to strengthening the clinical laboratory workforce H.R. 3248 - Diagnostic Lab Testing Transparency Act H.R. 5378 - Lower Costs, More Transparency Act H.R. 2369 - the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023 Food and Drug Administration (FDA) policies related to diagnostics and laboratory regulation

LobbyistCovered position, as disclosed
EMMA LANGE —
SHERRY HARPER WIDICUS —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 3248 (118th), H.R. 2369 (118th), H.R. 5378 (118th)

Medicare/Medicaid MMM

P.L. 117-328/H.R. 2617- Consolidated Appropriations Act of 2023, provisions related to Medicare reimbursement for clinical diagnostics laboratory services H.R. 2377/S. 1000 - Saving Access to Laboratory Services Act, provisions related to Medicare reimbursement for clinical diagnostics laboratory services P.L. 118-22/H.R. 6363 - Further Continuing Appropriations and Other Extensions Act, 2024 H.R. 4917 - Expanding Seniors Access to PFAS Testing Act Federal policy related to coverage and reimbursement of clinical laboratory services under the Medicare program

LobbyistCovered position, as disclosed
EMMA LANGE —
SHERRY HARPER WIDICUS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: H.R. 2377 (118th), S. 1000 (118th), H.R. 2617 (118th), H.R. 6363 (118th), H.R. 4917 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.